SCHEMBL8950348

SCHEMBL8950348

CC(C)n1ncnc1C(=O)NC1CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 2/20 0.41
SMYD3 Q9H7B4 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
BRD4 O60885 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TTK P33981 2/20 0.39
PDE4B Q07343 5/20 0.38
NPC1 O15118 1/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 1/20 0.38
RET P07949 1/20 0.37
KDR P35968 1/20 0.37
BRD2 P25440 1/20 0.37
BRD3 Q15059 1/20 0.37
BRDT Q58F21 1/20 0.37
PDE4D Q08499 1/20 0.37
TYK2 P29597 1/20 0.36
GRM5 P41594 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8995969 0.80 HPGD (0.43) SMYD3SMN1; SMN2L3MBTL1PDE4BTSHR
SCHEMBL8950240 0.79 PIK3CA (0.38) BRD4RETKDR
SCHEMBL8954913 0.76 BRD4 (0.40) SMN1; SMN2BRD4L3MBTL1PDE4BNPC1
SCHEMBL21490096 0.74 SMYD3 (0.55) SMYD3
SCHEMBL19710530 0.74 SMYD3 (0.55) SMYD3
SCHEMBL1431710 0.73 KDM4E (0.36) SMN1; SMN2KDM4E
SCHEMBL1485662 0.73 SRC (0.35) KDRKDM4E
SCHEMBL12410910 0.72 NPSR1 (0.33) L3MBTL1TSHRKDRKDM4EHTT
SCHEMBL18018738 0.72 DGAT1 (0.33)
SCHEMBL12410702 0.72 PIK3CA (0.39) RETKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188085-B2 Antifungal agents MERCK SHARP & DOHME CORP. (US) 2012-05-29 US disclosed
US-20100113439-A1 Antifungal agents MERCK & CO., INC. (US) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113439-A1 Antifungal agents GMDS, GBA3, UGGT1 HTR4 4600/4885SMYD3 3041/4885SMN1; SMN2 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.